Previous study proved that ANXA2 knockdown in rodent glioma GL261 cells reduces migration in vitro, slows tumor growth, invasion, proliferation, angiogenesis and increases tumor cell death in vivo34. Here, ANXA2 is linked to central nervous system cancer.